Donate now

Florence Guida Scientist
Environment and Lifestyle Epidemiology

Speciality: Molecular Epidemiology
Year Degree Major Institution Country/Town
2012 PhD Public Health -Epidemiology University Paris-Sud 11 France / Paris
2008 MSc Environment and Public Health University Paris Descartes France / Paris
2008 Doctorate Pharmacy University Montpellier I France / Montpellier
Current Research Projects

Biomarkers of lung cancer risk
Paul Brennan, Mattias Johansson, Peng Li

A comprehensive investigation into the metabolic pathways of renal cell carcinoma (RCC) – the MetKid project.
Mattias Johansson

Selected Publications

Baglietto L, Ponzi L, Haycock P, Hodge A, Assumma MB, Jung C, et al. DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. (2016 in press) Int J Cancer

Castagné R, Delpierre C, Kelly-Irving M, Campanella G, Guida F, Krogh V. A life course approach to explore the biological embedding of socioeconomic position and social mobility through circulating inflammatory markers. (2016) Sci Rep. 6:25170

Guida F*, Sandanger TM*, Campanella G*, Polidoro S, Castagné R, Palli D, et al. Genome-Wide Methylation Identifies Reversible and Irreversible Changes After Smoking Cessation. (2015) Hum Mol Genet. 24(8):2349-59

Fasanelli F*, Baglietto L*, Ponzi E, Guida F, Campanella G, Johansson M, et al. P. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. (2015) Nat Commun. 6:10192

Guida F, Paget-Bailly S, Lamkarkach F, Gaye O, Ducamp S., Menvielle G. Risk of lung cancer associated with occupational exposure to mineral wools: Updating knowledge from a French population-based case-control study, the ICARE study. (2013) J Occup Environ Med. 55(7):786-95

Close Reading Mode
Publication status

Published in section: WHO'S WHO

Publication date: 6 June, 2019, 9:56

Direct link: https://d2u7e27yy6nebm.cloudfront.net/staff_member/florence-guida/

© Copyright International Agency on Research for Cancer 2024